BETA vs BIIB · rev $8.9M vs P/E 21, rev $9.89B
Beta Technologies, Inc. (BETA) versus Biogen Inc (BIIB) — a side-by-side from cached financials, not a winner call.
Beta Technologies, Inc. (BETA) is a aerospace & defense company listed on NYSE.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Latest reported BETA revenue for 2025-09-30 was $8.9M. Net income was -$437.2M. Revenue was up 190.9% from 2024-09-30 to 2025-09-30. BETA currently screens at market cap $3.72B.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
BETA currently screens at market cap $3.72B. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Not investment advice. Open the BETA and BIIB stock pages for the full models.
Not investment advice.